Skip to main content
Print Save

Logo (Actavis) 3117 Logo (Actavis) 3117 (Morphine Sulfate Extended-Release 75 mg)

Pill with imprint Logo (Actavis) 3117 Logo (Actavis) 3117 is Brown, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 75 mg. It is supplied by Actavis Elizabeth LLC.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 75 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 3117 Logo (Actavis) 3117

Morphine sulfate extended-release 75 mg Logo (Actavis) 3117 Logo (Actavis) 3117
Morphine sulfate extended-release 75 mg Logo (Actavis) 3117 Logo (Actavis) 3117

Save up to 80% off prescription medications

Click here for your free Discount Card

Morphine Sulfate Extended-Release

Imprint
Logo (Actavis) 3117 Logo (Actavis) 3117
Strength
75 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Elizabeth LLC
National Drug Code (NDC)
00228-3117
Inactive Ingredients
diethyl phthalate, ethylcellulose, gelatin, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol, sucrose, magnesium silicate, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, butyl alcohol, alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, water, shellac, ammonia

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer